Although we have validated the upregulation of NLRC4, TXN, and S100A9 expression in the peripheral blood of sepsis patients through qRT-PCR, there are still some deficiencies, such as limited number of enrolled patients and the lack of multicenter validation. This evidence concerns the gene TXN and Sepsis.